NICE guidelines on treating schizophrenia - Audit [8]

Psychiatric Bulletin

Volumn 32, Issue 2, 2008, Pages 75-

  Macpherson, Rob ^a   Hovey, Nicola ^b   Ranganath, Krishen ^a   Uppal, Amjad ^a   Thompson, Andy ^c  

^a Gloucestershire Partnership NHS Trust ^*  (United Kingdom)

^b Gloucestershire Health and Care NHS Foundation Trust   (United Kingdom)

^c THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL PRACTICE; CLINICAL PROTOCOL; COGNITIVE THERAPY; FAMILY THERAPY; HUMAN; INTERVENTION STUDY; LETTER; MEDICAL AUDIT; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN ATTITUDE; POLYPHARMACY; SCHIZOPHRENIA; TREATMENT PLANNING;

EID: 39549085338     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.32.2.75     Document Type: Letter

References (3)

1. DENT, T. H. & SADLER, M. (2002) From guidance to practice: why NICE is not enough. BMJ, 324, 842-845.
2. DOPSON, S., LOCOCK, L., CAMBERS, D., et al (2001) Implementation of evidence-based medicine: evaluation of the Promoting Action on Clinical Effectiveness programme. Journal of Health Services Research and Policy, 187, 248-255.
3. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (2002) Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. http://www.nice.org.uk/guidance/ index.jsp?action=byID&o=10916.